<DOC>
	<DOCNO>NCT01576705</DOCNO>
	<brief_summary>Evaluation follow young child Down syndrome : - efficacy systematic treatment L-thyroxine control dos ( clinically ultrasensitive thyreostimulating hormone ( TSH ) assay ) , - efficacy systematic folinic acid treatment dose 1 mg/kg/o.i.d , - interaction two treatment .</brief_summary>
	<brief_title>Efficacy Assessment Systematic Treatment With Folinic Acid Thyroid Hormone Psychomotor Development Down Syndrome Young Children</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>patient karyotype demonstrate homogeneous , free Robertsonian translocation trisomy 21 patient undergone cardiac ultrasound demonstrate severe heart disease patient age 6 18 month inclusion congenital hypothyroidism hypothyroidism demonstrate laboratory test ( TSH &gt; 7mUI/l ) presenting present hyperthyroidism present present leukaemia present present West syndrome form epilepsy unstable neurological disease present present sign central nervous system distress : stroke , postoperative hypoxia , meningitis ) present severe heart disease cardiac ultrasound , haemodynamic effect present noncontrolled cardiac arrhythmia Apgar &lt; 7 5 min birth Gestational age &lt; 231 day ( 33 gestation week )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>Young child</keyword>
	<keyword>Psychomotor development</keyword>
	<keyword>Thyroid hormone</keyword>
	<keyword>Folinic acid</keyword>
	<keyword>Psychometric test</keyword>
	<keyword>GMDS</keyword>
	<keyword>Griffiths</keyword>
	<keyword>Genetic factor</keyword>
	<keyword>Biochemical factor</keyword>
</DOC>